{"id":"W2141303400","doi":"10.1093/annonc/mdu517","title":"Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Erlotinib; Medicine; Erlotinib Hydrochloride; Internal medicine; Lung cancer; Hazard ratio; Clinical endpoint; Oncology; Regimen; Randomized controlled trial; Adverse effect; Phases of clinical research; Gastroenterology; Clinical trial; Epidermal growth factor receptor; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002046301,0.00250782,0.004320286,0.0005243654,0.0006755158,0.002035845,0.001482541,0.001961886,0.008287592],"category_scores_gemma":[0.001745102,0.001360352,0.002802811,0.0005897752,0.001888909,0.002260722,0.00069373,0.006024633,0.001883565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001820947,"about_ca_system_score_gemma":0.001759232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002358348,"about_ca_topic_score_gemma":0.006192438,"domain_scores_codex":[0.9993088,0.0003138899,0.00003655666,0.0001512283,0.00003455458,0.0001548851],"domain_scores_gemma":[0.9990778,0.0002058836,0.0001855821,0.00008607389,0.000053902,0.0003907317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847565,0.003781075,0.0004848698,0.0002292614,0.0007537975,0.00002655374,0.00003810503,0.0004615773,0.001304366,0.00009420963,0.0008790176,0.00719067],"study_design_scores_gemma":[0.9619325,0.03559836,0.000971318,0.00001356608,0.0003604892,0.00002431364,0.00002410346,0.0003382808,0.0001727452,0.0001250623,0.0004276761,0.00001172028],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821393,0.004212721,0.000918972,0.001877537,0.001703924,0.003269164,0.001975216,0.0002266729,0.003676582],"genre_scores_gemma":[0.9844187,0.002121458,0.001678979,0.001602462,0.0006413955,0.002752448,0.002041895,0.00006037427,0.004682213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008287592,"threshold_uncertainty_score":0.02772474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03339481456787664,"score_gpt":0.3862463530074766,"score_spread":0.3528515384395999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}